Form 8-K - Current report:
SEC Accession No. 0001564590-19-000269
Filing Date
2019-01-07
Accepted
2019-01-07 07:01:43
Documents
48
Period of Report
2019-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20190107.htm 8-K 24437
2 EX-99.1 clsd-ex991_6.htm EX-99.1 39044
3 GRAPHIC gnzrf1d2tgye000027.jpg GRAPHIC 321408
4 GRAPHIC gnzrf1d2tgye000005.jpg GRAPHIC 297942
5 GRAPHIC gnzrf1d2tgye000007.jpg GRAPHIC 188396
6 GRAPHIC gnzrf1d2tgye000034.jpg GRAPHIC 291776
7 GRAPHIC gnzrf1d2tgye000028.jpg GRAPHIC 137004
8 GRAPHIC gnzrf1d2tgye000018.jpg GRAPHIC 168679
9 GRAPHIC gnzrf1d2tgye000046.jpg GRAPHIC 262232
10 GRAPHIC gnzrf1d2tgye000009.jpg GRAPHIC 317107
11 GRAPHIC gnzrf1d2tgye000017.jpg GRAPHIC 172219
12 GRAPHIC gnzrf1d2tgye000043.jpg GRAPHIC 292873
13 GRAPHIC gnzrf1d2tgye000040.jpg GRAPHIC 339597
14 GRAPHIC gnzrf1d2tgye000024.jpg GRAPHIC 269736
15 GRAPHIC gnzrf1d2tgye000023.jpg GRAPHIC 105166
16 GRAPHIC gnzrf1d2tgye000011.jpg GRAPHIC 211240
17 GRAPHIC gnzrf1d2tgye000020.jpg GRAPHIC 183523
18 GRAPHIC gnzrf1d2tgye000019.jpg GRAPHIC 133804
19 GRAPHIC gnzrf1d2tgye000013.jpg GRAPHIC 261481
20 GRAPHIC gnzrf1d2tgye000001.jpg GRAPHIC 231116
21 GRAPHIC gnzrf1d2tgye000032.jpg GRAPHIC 190701
22 GRAPHIC gnzrf1d2tgye000029.jpg GRAPHIC 310489
23 GRAPHIC gnzrf1d2tgye000008.jpg GRAPHIC 233936
24 GRAPHIC gnzrf1d2tgye000021.jpg GRAPHIC 240904
25 GRAPHIC gnzrf1d2tgye000035.jpg GRAPHIC 131083
26 GRAPHIC gnzrf1d2tgye000022.jpg GRAPHIC 173016
27 GRAPHIC gnzrf1d2tgye000041.jpg GRAPHIC 233054
28 GRAPHIC gnzrf1d2tgye000014.jpg GRAPHIC 233174
29 GRAPHIC gnzrf1d2tgye000010.jpg GRAPHIC 180594
30 GRAPHIC gnzrf1d2tgye000015.jpg GRAPHIC 142578
31 GRAPHIC gnzrf1d2tgye000033.jpg GRAPHIC 117449
32 GRAPHIC gnzrf1d2tgye000038.jpg GRAPHIC 272822
33 GRAPHIC gnzrf1d2tgye000042.jpg GRAPHIC 225784
34 GRAPHIC gnzrf1d2tgye000039.jpg GRAPHIC 225465
35 GRAPHIC gnzrf1d2tgye000025.jpg GRAPHIC 211521
36 GRAPHIC gnzrf1d2tgye000030.jpg GRAPHIC 191384
37 GRAPHIC gnzrf1d2tgye000036.jpg GRAPHIC 210170
38 GRAPHIC gnzrf1d2tgye000016.jpg GRAPHIC 153860
39 GRAPHIC gnzrf1d2tgye000044.jpg GRAPHIC 184322
40 GRAPHIC gnzrf1d2tgye000037.jpg GRAPHIC 202155
41 GRAPHIC gnzrf1d2tgye000031.jpg GRAPHIC 173901
42 GRAPHIC gnzrf1d2tgye000003.jpg GRAPHIC 153086
43 GRAPHIC gnzrf1d2tgye000002.jpg GRAPHIC 544472
44 GRAPHIC gnzrf1d2tgye000006.jpg GRAPHIC 245560
45 GRAPHIC gnzrf1d2tgye000012.jpg GRAPHIC 156028
46 GRAPHIC gnzrf1d2tgye000045.jpg GRAPHIC 290646
47 GRAPHIC gnzrf1d2tgye000004.jpg GRAPHIC 265722
48 GRAPHIC gnzrf1d2tgye000026.jpg GRAPHIC 222851
  Complete submission text file 0001564590-19-000269.txt   14256958
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 19512139
SIC: 2834 Pharmaceutical Preparations